Monday, 26 August 2019

Pharma News

  • Teva, Xenon enter $335 mn deal for pain drug

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 12 Dec, 2012

    Singapore: Israel-based Teva Pharmaceutical and Canada-based Xenon Pharmaceuticals have entered into a collaborative development and exclusive worldwide license for XEN402. XEN402 is curre...Read more

  • Dong-A Pharma appoints new co-CEO

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 04 Mar, 2013

    Singapore: Korea-based Dong-A Pharmaceutical has appointed Mr Lee Dong Hun as its new co-chief executive officer. He would be replacing Mr Kim Won Bae, effective March 4, 2013. The current ...Read more

  • Mitsubishi and Daiichi Sankyo to launch diabetes drug in Japan

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 Aug, 2012

    Singapore: Mitsubishi Tanabe Pharma and Daiichi Sankyo will launch selective DPP-4 inhibitor Tenelia 20mg tablets (teneligliptin hydrobromide hydrate tablets) in Japan on September 10, 2012...Read more

  • Alzheimer's Association calls for early detection

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2013

    Singapore: Alzheimer's Association, US, is making efforts to improve early detection and diagnosis of Alzheimer's disease and increase the use of information and support services. The vario...Read more

  • China to expand list of price-controlled drugs

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 21 Aug, 2012

    Singapore: China is set to increase the number of products on its price-controlled "essential drugs" list. Report from Reuters and the official Shanghai Securities Journal reported that the...Read more

  • Lilly cancer drug patent gets US court nod

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 27 Aug, 2012

    Singapore: The US Court of Appeals for the Federal Circuit has affirmed a prior ruling by the US District Court for the District of Delaware that Eli Lilly's compound patent for Alimta (pem...Read more

  • Bangalore gets medical quality assesment lab

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: CSA Group, global testing and certification service provider with operations in China, has launched a testing and certification laboratory in Bangalore, India. The new laborator...Read more

  • AseaCyte gets BioSpectrum award for drug discovery efforts

    Pharma |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundation (CARIF), a non-profit cancer research institute in Malaysia; and Dr...Read more

  • Sinopharm to build China's largest R&D center

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 07 Aug, 2013

    Singapore: Sinopharm Group is going to build China's largest Biotechnology Research Institute in Wuhan East Lake High-tech Zone. The facility will showcase all of Sinopharm's existing biote...Read more

  • Pic Gallery - 7th in-Pharma Japan and 26th Interphex Japan

    Pharma |  Analysis | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    7th in-Pharma Japan and 26th Interphex Japan, which was held from July 10-12, 2013, at Tokyo Big Sight, Japan...Read more

  • Roche gives up its patent battle in India

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 19 Aug, 2013

    Singapore: Roche will not pursue patent application for its breast cancer drug Herceptin in India. However, Roche said that it would continue to enforce other patents covering its drugs in ...Read more

  • Europe approves Astrazeneca's lung cancer drug

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 21 Dec, 2015

    Singapore: European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation for AstraZeneca's Tagrisso (osimertinib) for the treatment of adults with locally a...Read more

  • Janssen MDR-TB drug gets FDA nod

    Pharma |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Jan, 2013

    Singapore: Janssen Therapeutics received US FDA accelerated approval to Sirturo (bedaquiline) Tablets for the treatment of pulmonary multi-drug resistant tuberculosis (MDR-TB) as part of co...Read more

  • Takeda subsidiary suspended for 'no drug label'

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 20 Feb, 2013

    Singapore: Takeda Pharmaceutical received an Order for Corrective Action regarding the manufacturing and marketing of Alinamin-F5 Injection from the Osaka Prefectural Government, citing a v...Read more

  • FDA committee votes against Xarelto

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 28 May, 2012

    Singapore: US Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee has voted against the approval of Xarelto (rivaroxaban), an oral anticoagulant, to reduc...Read more

  • Abraxane cancer trial shows positive results in Australia

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 29 Oct, 2012

    Singapore: Specialised Therapeutics Australia (STA) is going to publish abstracts related to its phase III metastatic melanoma study with Abraxane (nanoparticle albumin-bound paclitaxel) at...Read more

  • Dutch company acquires Indian pharma distributor

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Mumbai: IMCD Group acquired the business of Indchem International, an established player in the pharmaceutical ingredients market in India. The business of Mumbai-based Indchem has already...Read more

  • Bayer colorectal cancer drug gets Japanese nod

    Pharma |  News | By BioSpectrum Bureau  | 0 Comment | 26 Mar, 2013

    Singapore: Japan's Ministry of Health, Labor and Welfare (MHLW) has approved Bayer HealthCare and Onyx Pharmaceuticals's Stivarga (regorafenib) tablets for the treatment of patients with me...Read more



Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls